Wolverine Trading, LLC Iveric Bio, Inc. Put Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 23, 2023	SELL	$26.24 - $39.63 $228,288 - $344,781	-8,700 Reduced 37.83%	14,300 $562,000
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $429,410 - $564,880	23,000 New	23,000 $547,000
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $200,220 - $395,967	21,300 New	21,300 $368,000
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $685,968 - $931,488	-49,600 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.07 - $17.5 $350,672 - $868,000	49,600 New	49,600 $770,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.